Actavis' P2P Acquisition

Actavis raised a round of funding on October 15, 2012. Investors include Allergan.

Actavis is a specialty pharmaceutical company focused on developing, manufacturing and commercializing high quality affordable generic and innovative branded pharmaceutical products for patients aroun…

Articles about Actavis' P2P Acquisition: